Follow
Melanoma
Melanoma is a type of skin cancer that is created by melanocyctes that have mutated. Melanocytes are pigment cells that are found on the skin. However, melanoma can occur in the intestines and eyes in more rare cases. Melanoma is a common form of cancer and considered the most dangerous form, there a more than 200,000 cases per year. Treatment can include: radiation, surgery, medication, or chemotherapy.
What's Popular in Melanoma
-
NOV 06, 2025Immunology
Neuroblastoma RAS viral oncogene homolog (NRAS)-mutant melanoma is an aggressive form of skin cancer that develops becau ...Written By: Brian G. MorrealeNOV 04, 2025Drug Discovery & Development
COVID-19 mRNA vaccines significantly increased survival times in patients with advanced lung and skin cancer undergoing ...Written By: Annie LennonOCT 25, 2025Cancer
A study presented at the annual European Society of Medical Oncology Congress 2025 and published in the journal Annals o ...Written By: Katie KokolusOCT 21, 2025Drug Discovery & Development
Nicotinamide, a vitamin B3 derivative, could significantly reduce skin cancer risk.Written By: Annie LennonOCT 14, 2025Drug Discovery & Development
A newly developed nanoparticle-based vaccine successfully prevented melanoma, pancreatic, and triple-negative breast can ...Written By: Annie Lennon
NOV 06, 2025
Immunology
Neuroblastoma RAS viral oncogene homolog (NRAS)-mutant melanoma is an aggressive form of skin cancer that develops becau
...
Written By:
Brian G. Morreale
NOV 04, 2025
Drug Discovery & Development
COVID-19 mRNA vaccines significantly increased survival times in patients with advanced lung and skin cancer undergoing
...
Written By:
Annie Lennon
OCT 25, 2025
Cancer
A study presented at the annual European Society of Medical Oncology Congress 2025 and published in the journal Annals o
...
Written By:
Katie Kokolus
OCT 21, 2025
Drug Discovery & Development
Nicotinamide, a vitamin B3 derivative, could significantly reduce skin cancer risk.
Written By:
Annie Lennon
OCT 14, 2025
Drug Discovery & Development
A newly developed nanoparticle-based vaccine successfully prevented melanoma, pancreatic, and triple-negative breast can
...
Written By:
Annie Lennon
SEP 26, 2025
Cancer
Cancer immunotherapies, anti-cancer treatments that target a patient’s own immune system, working to make it more
...
Written By:
Katie Kokolus
SEP 15, 2025
Cancer
Plasticity in cancer cells describes their inherent ability to undergo alterations and turn certain features on and off
...
Written By:
Katie Kokolus
SEP 11, 2025
Immunology
Breast cancer is one of the most common cancers among American women. It is estimated that within the United States, abo
...
Written By:
Brian G. Morreale
SEP 04, 2025
Cancer
Immunotherapies have made significant strides in treating advanced cancers, a feat that was once considered impossible.&
...
Written By:
Katie Kokolus
-
NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...APR 30, 2025 | 8:00 AM
The MAF bZIP Transcription Factor G (MAFG) is a member of the small MAF family of proteins. Previously, we have shown that miRNA-29 suppresses melanoma development, at least in part, by repr...OCT 30, 2024 | 8:00 AMC.E. CREDITS
Predicting patient outcomes in cancer treatment is key to creating personalized and effective therapeutic plans. Join Dr. Osman in this engaging webinar as she delves into the cutting-edge w...On Demand
The capture of tumor-derived extracellular vesicles (TEVs) by cells in the tumor microenvironment (TME) contributes to metastasis and notably to the formation of the pre-metastatic niche (PM...
NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...
APR 30, 2025 | 8:00 AM
The MAF bZIP Transcription Factor G (MAFG) is a member of the small MAF family of proteins. Previously, we have shown that miRNA-29 suppresses melanoma development, at least in part, by repr...
OCT 30, 2024 | 8:00 AM
C.E. CREDITS
Predicting patient outcomes in cancer treatment is key to creating personalized and effective therapeutic plans. Join Dr. Osman in this engaging webinar as she delves into the cutting-edge w...
On Demand
The capture of tumor-derived extracellular vesicles (TEVs) by cells in the tumor microenvironment (TME) contributes to metastasis and notably to the formation of the pre-metastatic niche (PM...
MAY 24, 2022 | 11:00 AM
Date: May 24, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 7:00pm (CEST) NGS tumor profiling has become the mainstay of modern cancer therapy. Several NCCN-guided and FDA-approved therapies are c...
Speaker:
Dr. Christopher Lum, M.D.
, Zan Halford, M.S. SMB(ASCP)CM,
Sponsored By: BioDiscovery, A Bionano Genomics Company
MAR 31, 2022 | 11:00 AM
Date: March 31, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CET) Formalin-fixed paraffin-embedded (FFPE) tissues are the most widely used clinical sample types in histology and molecular...
FEB 23, 2022 | 6:00 AM
Cancer still accounts for nearly 1 in every 4 deaths worldwide. New immunotherapies have the power to induce durable responses in patients with fatal cancers, but only a small percentage of...
Speaker:
Hans-Dieter Zucht, PhD
Presented at: Drug Discovery & Development Virtual Event Series 2022
Sponsored By: Luminex - A DiaSorin Company
Sponsored By: Luminex - A DiaSorin Company
DEC 07, 2021 | 10:00 AM
Date: December 07, 2021 Time: 10:00am (PST) The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights in...
-
SEP 25, 2024 | 11:30 PM PDT
Join us at the Olink Proteomics Conference , a novel platform for scientists exploring the latest advancements in proteomics and proteogenomic on immunology, oncology, neuroscience, ageing,...SEP 13, 2022 | 11:00 AM PDT
Tandem Mass Tags (TMT) are isobaric labels that allow for simultaneous identification and quantification of protein expression from multiple samples in a single LC-MS analysis. Join us for t...SEP 14, 2021 | 7:00 AM PDT
Working in Tandem : 1st annual TMT Symposia Tandem Mass Tags (TMT) are isobaric labels that allow for simultaneous identification and quantification of protein expression from multiple sampl...SEP 08, 2021 | 6:00 AM PDT
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...OCT 13, 2020 | 1:00 PM
The Power of Omics is a three-day Thermo Fisher Scientific virtual event that focuses on harnessing the power of omics to advance scientific research. The virtual event will feature a series...
SEP 25, 2024
| 11:30 PM PDT
Join us at the Olink Proteomics Conference , a novel platform for scientists exploring the latest advancements in proteomics and proteogenomic on immunology, oncology, neuroscience, ageing,...
SEP 13, 2022
| 11:00 AM PDT
Tandem Mass Tags (TMT) are isobaric labels that allow for simultaneous identification and quantification of protein expression from multiple samples in a single LC-MS analysis. Join us for t...
SEP 14, 2021
| 7:00 AM PDT
Working in Tandem : 1st annual TMT Symposia Tandem Mass Tags (TMT) are isobaric labels that allow for simultaneous identification and quantification of protein expression from multiple sampl...
SEP 08, 2021
| 6:00 AM PDT
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...
OCT 13, 2020
| 1:00 PM
The Power of Omics is a three-day Thermo Fisher Scientific virtual event that focuses on harnessing the power of omics to advance scientific research. The virtual event will feature a series...
SEP 29, 2020
| 8:00 AM PDT
2nd ANNUAL PAWS FOR A CURE VIRTUAL EVENT RESEARCH SYMPOSIUM Translational Potential Of Comparative Approaches To Accelerate Drug Development In Shared Childhood & Canine Cancers We are...
FEB 27, 2019
| 6:00 AM PST
Labroots and the Drug Discovery planning committee are pleased to announce its 2nd annual event in the Drug Discovery Virtual Event Series....
OCT 10, 2018
| 6:00 AM PDT
The 6th Annual Event in the Cancer Research & Oncology Week Virtual Event Series will take place October 2018....
MAY 09, 2018
| 6:00 AM PDT
C.E. CREDITS
LabRoots is excited to announce the 6th Annual Event in the Genetics and Genomics Virtual Event Series!...